tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Belite Bio, Inc. ADR (BLTE)
NASDAQ:BLTE
US Market
BLTE
Belite Bio, Inc. ADR
Overview
Analyst Forecasts
Financials
Dividends
Technical Analysis
Chart
Earnings
Ownership
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Belite Bio, Inc. ADR (BLTE) Stock News & Sentiment

Compare
27 Followers
Promising Phase 3 Results for Belite Bio’s Tinlarebant in Stargardt Disease Boost Buy Rating
Premium
Ratings
Promising Phase 3 Results for Belite Bio’s Tinlarebant in Stargardt Disease Boost Buy Rating
24h ago
BLTE
Belite Bio’s Phase 3 Trial for Stargardt Disease Drug Advances
Premium
Company Announcements
Belite Bio’s Phase 3 Trial for Stargardt Disease Drug Advances
2d ago
6K
BLTE
Belite Bio Announces $15 Million Direct Offering to Enhance Financial Position
Premium
Company Announcements
Belite Bio Announces $15 Million Direct Offering to Enhance Financial Position
23d ago
6K
BLTE
Belite Bio Advances in Retinal Disease Trials
Premium
Company Announcements
Belite Bio Advances in Retinal Disease Trials
4M ago
BLTE
Belite Bio Advances in Tinlarebant Trials, Appoints New CMO
Premium
Company Announcements
Belite Bio Advances in Tinlarebant Trials, Appoints New CMO
4M ago
6K
BLTE
Is BLTE a Buy, Before Earnings?
Premium
Pre-Earnings
Is BLTE a Buy, Before Earnings?
4M ago
BLTE
Belite Bio Offers New Warrant Opportunities to Investors
Premium
Company Announcements
Belite Bio Offers New Warrant Opportunities to Investors
4M ago
6K
BLTE
More BLTE News >

BLTE News on the Web

Belite Bio's Phase 3 DRAGON Trial for Tinlarebant Recommended to Continue Without Modifications by Data Safety Monitoring Board
Quiver Quantitative
Neutral
Belite Bio Announces Interim Analysis Results from the Pivotal Global Phase 3 DRAGON trial of Tinlarebant in Adolescent Stargardt Disease Subjects
Yahoo Finance
Neutral
Belite Bio Announces Registered Direct Offering of $15 Million
Yahoo Finance
Neutral
Belite Bio is Now Oversold (BLTE)
BNK Invest
Neutral
Belite Bio Announces Presentations at the American Academy of Ophthalmology 2024 Annual Meeting
Yahoo Finance
Neutral
Belite Delights Investors, Soleno, ADMA, Harrow Deliver Triple-digit Gains, Keep An Eye On Oculis
rttnews
Neutral
Belite Bio to Participate in the Maxim Group 2024 Healthcare Virtual Summit
Yahoo Finance
Neutral
Belite Bio Becomes Oversold (BLTE)
BNK Invest
Neutral

News Score - Last 7 Days

Neutral
BLTE
Sector Average
Media Buzz
This Week2 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average55%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is BLTE’s Media Buzz Sentiment?
2 articles about BLTE were published this week. In an average week, 1 articles are published.
    What is BLTE’s weekly average amount of articles?
    In an average week, 1 articles about BLTE are published.
      What is BLTE’s News Sentiment?
      50% of articles about BLTE were positive this week, compared to its sector average of 55%.
        Healthcare Stocks that are Trending in the News
        CCCCC4 Therapeutics
        RAFLFRaffles Medical Group
        CADLCandel Therapeutics
        CORTCorcept Therapeutics
        TMDXTransMedics Group
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing